Pharmos(PARS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS)

PARS 2.700

+13.6%

Jan 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: yosi s who wrote (493)	3/30/1998 6:00:00 PM
From: arnie h	Read Replies (3) of 1491

Yosi: Here's one; Cephalon got an approvable letter for Provigil, a drug for narcolepsy. Of course, the other side of the coin is that their Myatrophin is up for review again in April, after being turned down last year. A situation for a real gambler, if you are one. On the Pharmos side, I certainly agree better medicine wins out at the end of the day. The only point I was making is that it sometimes takes more time than one might expect just from the medical aspects. My comments are just aimed at trying to take the sting out so you fellows will hang around when the Elliot gang knocks the stock back. In the meantime, I certainly feel a better about my investment at $3 than I did at $2. I'd be delighted if that turns out to be the floor. Regards, Arnie

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next